U.S. Department of Health and Human Services
NATIONAL INSTITUTES OF HEALTH NIH News
National Institute on Aging (NIA) <https://www.nia.nih.gov/>
National Institute of Neurological Disorders and Stroke (NINDS) <https://www.ninds.nih.gov/>
For Immediate Release: Monday, March 11, 2019
CONTACT: NINDS Press Team, 301-496-5751, <e-mail:nindspressteam@xxxxxxxxxxxxx, NIA Office of Communications and Public Liaison, 301-496-1752, <e-mail:nianews3@xxxxxxxxxxxx>
MEDIA ADVISORY
NIH DEMENTIA 101 BRIEFING: HEAR THE FULL STORY BEHIND DEMENTIA AND ALZHEIMER’S
WHAT
On Thursday March 14, 2019, the National Institutes of Health will host a “Dementia 101” briefing and discussion for reporters. During the event, four experts will paint a full picture of the impact dementia has on public health, highlighting that it is a much bigger problem than many realize and that several disease pathways converge to cause dementia. The goal of the briefing is to provide reporters with an in-depth understanding of dementia and spark new story ideas. Some of the topics covered will include:
-- What’s behind dementia, Alzheimer’s disease, and Alzheimer’s-related dementias?
-- What’s the connection between high blood pressure and cognitive impairment?
-- Is there a link between traumatic brain injury and dementia risk?
-- Do health disparities impact dementia risk?
The briefing will be held during the Alzheimer’s Disease-Related Dementias (ADRD) Summit <https://www.ninds.nih.gov/News-Events/Events-Proceedings/Events/Alzheimers-Disease-Related-Dementias-Summit-2019>. Alzheimer’s disease and related dementias currently affect more than 5 million older Americans and that number may increase to 13.2 million by 2050. To address this growing problem, experts from around the world will gather at this two-day event, March 14 - 15, 2019 at the NIH. The summit will address the current state of high-priority research areas as well as emerging topics.
WHO
The following experts will lead the discussion and be available for interviews:
-- Richard J. Hodes, M.D., director, National Institute on Aging
-- Walter Koroshetz, M.D., director, National Institute of Neurological Disorders and Stroke <https://www.ninds.nih.gov/1.
-- Julie A. Schneider, M.D., M.S, professor, Department of Pathology, Rush University Medical Center, Chicago, IL, scientific chair ADRD Summit 2019
-- Roderick Corriveau, Ph.D., program director, National Institute of Neurological Disorders and Stroke, NIH lead for ADRD Summit 2019
WHEN AND WHERE:
12:30 – 1:30 p.m. EDT, Thursday, March 14, 2019; Room G1/G2 of the NIH’s Natcher Conference Center (Building 45).
The ADRD Summit is open to the public and itself will provide insights from leading experts in the field. In addition to the briefing, reporters are encouraged to attend both days of the summit to get a broader understanding of dementia research efforts and priorities. See the full summit agenda at <https://meetings.ninds.nih.gov/Home/Agenda/21149>.
If you are planning to attend or have any questions, please contact the NINDS press team at nindspressteam@xxxxxxxxxxxxx; 301-496-5751
NINDS <http://www.ninds.nih.gov> is the nation’s leading funder of research on the brain and nervous system. The mission of NINDS is to seek fundamental knowledge about the brain and nervous system and to use that knowledge to reduce the burden of neurological disease.
About the National Institute on Aging (NIA): The NIA leads the federal government effort conducting and supporting research on aging and the health and well-being of older people. The NIA provides information on age-related cognitive change and neurodegenerative disease specifically at its Alzheimer’s Disease Education and Referral (ADEAR) Center <https://www.nia.nih.gov/health/alzheimers>. For more on health and on aging generally, visit the NIA website <https://www.nia.nih.gov/>. To sign up for e-mail alerts about new findings or publications, please visit either website.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit <www.nih.gov>.
NIH...Turning Discovery into Health -- Registered, U.S. Patent and Trademark Office
###
To subscribe (or unsubscribe) from NIH News Release mailings, go to
<http://service.govdelivery.com/service/subscribe.html?code=USNIH_1>.
If you subscribed via the NIH LISTSERV, go to <https://list.nih.gov/cgi-bin/wa.exe?A0=nihpress>.
